Clarity Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CLRP.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
29 Apr 24	BuyUS$57,025	Robert Thomas	Individual	34,092	US$1.67
29 Nov 23	SellUS$256,420	Charles Morgan	Individual	300,000	US$0.85
01 Sep 23	SellUS$3,207,650	Charles Morgan	Individual	5,000,000	US$0.64

Insider Buying: CLRP.F insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.4%.

Top 21 shareholders own 36.39% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.04%	TM Ventures Pty Ltd.	18,788,460	US$54.2m	200%	no data
5.76%	Christopher Roberts	17,911,280	US$51.7m	0%	no data
4.52%	Alan Taylor	14,066,660	US$40.6m	0%	no data
2.97%	Argo Investments Limited	9,247,447	US$26.7m	0%	0.54%
2.51%	Yarrawah Pty Ltd	7,803,450	US$22.5m	0%	no data
2.41%	Vantres Pty Ltd	7,487,340	US$21.6m	0%	no data
2.12%	Charles Morgan	6,600,041	US$19.0m	0%	no data
1.95%	Matthew Harris	6,065,800	US$17.5m	0%	no data
1.61%	Smarter Capital Pty Ltd	5,004,543	US$14.4m	0%	no data
1.25%	Kylaco Pty Ltd	3,896,280	US$11.2m	0%	no data
1.16%	Australian Nuclear Science and Technology Organisation	3,599,920	US$10.4m	0%	no data
1%	Guido Belgiorno-Nettis	3,116,000	US$9.0m	0%	no data
0.95%	UM Commercialisation Pty Ltd	2,946,500	US$8.5m	0%	no data
0.89%	Malvin Eutick	2,768,320	US$8.0m	0%	no data
0.58%	Colin Biggin	1,801,304	US$5.2m	0%	no data
0.37%	Robert Thomas	1,159,092	US$3.3m	3.03%	no data
0.17%	Thomas Ramdahl	520,000	US$1.5m	333%	no data
0.075%	Portland Investment Counsel Inc.	234,235	US$675.5k	0%	0.2%
0.039%	Charles O'Bryan-Tear	120,000	US$346.0k	0%	no data
0.008%	Tony McCullough Foundation Trust, Endowment Arm	25,000	US$72.1k	0%	100.0%
0.008%	PFM Asset Management LLC	24,827	US$71.6k	0%	no data